Zobrazeno 1 - 10
of 280
pro vyhledávání: '"Toru, Arai"'
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7446 (2023)
Background: This study aimed to clarify the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). Methods: Eighty-six patients diagnosed with AE-IPF were included i
Externí odkaz:
https://doaj.org/article/371ad1b2f05b45bc8d2bf385ba0805b1
Autor:
Kazunobu Tachibana, Masanori Akira, Toru Arai, Chikatoshi Sugimoto, Seiji Hayashi, Yoshikazu Inoue
Publikováno v:
Canadian Respiratory Journal, Vol 2023 (2023)
Background. Pulmonary sarcoidosis predominantly affects the upper lung zones but sometimes affects the lower lung zones. We hypothesised that patients with lower lung zone-dominant sarcoidosis had lower baseline forced vital capacity, progressive res
Externí odkaz:
https://doaj.org/article/f21878b961ed4e5e866a5cad146f6bc2
Autor:
Corina N. D’Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, Masaaki Toda, Ahmed M. Abdel-Hamid, Hajime Fujimoto, Osamu Hataji, Hiroki Nakahara, Atsuro Takeshita, Kota Nishihama, Tomohito Okano, Haruko Saiki, Yuko Okano, Atsushi Tomaru, Valeria Fridman D’Alessandro, Miyako Shiraishi, Akira Mizoguchi, Ryoichi Ono, Junpei Ohtsuka, Masayuki Fukumura, Tetsuya Nosaka, Xuenan Mi, Diwakar Shukla, Kensuke Kataoka, Yasuhiro Kondoh, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Yutaka Yano, Roderick I. Mackie, Isaac Cann, Esteban C. Gabazza
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-23 (2022)
Here, the authors show that treatment with a monoclonal neutralizing antibody against the lung microbiota-derived proapoptotic peptide corisin ameliorates acute exacerbation of pulmonary fibrosis and severity of endotoxin-induced acute lung injury in
Externí odkaz:
https://doaj.org/article/c55325ad1d4042ecbf6c24f945542d94
Autor:
Atsushi Yanagisawa, Takayuki Takimoto, Yu Kurahara, Kazunari Tsuyuguchi, Shiomi Yoshida, Masaki Hirose, Yoshikazu Inoue, Toru Arai
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 14, p2043-2047, 5p
Autor:
Toru Arai, Yu Kurahara, Mitsuhiro Moda, Takehiko Kobayashi, Yoshinobu Matsuda, Tomoko Kagawa, Reiko Sugawara, Kazunari Tsuyuguchi, Yoshikazu Inoue
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 15, p 4940 (2023)
The prognosis of patients with coronavirus disease 2019 (COVID-19) and pre-existing interstitial lung disease (preILD) is poor, and no effective treatment strategy has been determined. The aim of this study was to assess the effectiveness of a steroi
Externí odkaz:
https://doaj.org/article/5c031c0ce4ee40b68ca578cd9d399886
Autor:
Teiko Sakurai, Toru Arai, Masaki Hirose, Kensuke Kojima, Tetsuki Sakamoto, Yoshinobu Matsuda, Chikatoshi Sugimoto, Hyung-Eun Yoon, Yoshikazu Inoue
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Patients with lymphangioleiomyomatosis (LAM) frequently experience pneumothorax. Although sirolimus is the standard therapy for LAM, its effect on pneumothorax is controversial. Recently, total pleural covering (TPC) and modified
Externí odkaz:
https://doaj.org/article/fee158e7a1ac487b97531e02ca80e47b
Autor:
Toru Arai, Yoshikazu Inoue
Publikováno v:
ERJ Open Research, Vol 8, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/04662cd8975148eb877678f0b8d9a4a5
Autor:
Masaki Hirose, Toru Arai, Chikatoshi Sugimoto, Takayuki Takimoto, Reiko Sugawara, Shojiro Minomo, Sayoko Shintani, Naoko Takeuchi, Kanako Katayama, Yasushi Inoue, Tomoko Kagawa, Takahiko Kasai, Masanori Akira, Yoshikazu Inoue
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background Autoimmune pulmonary alveolar proteinosis (APAP) results from the suppression of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling by a neutralizing autoantibody against GM-CSF. B cell-activating factor (BAFF) an
Externí odkaz:
https://doaj.org/article/bb8074ba53104c0d8efa7e0a63cef45d
Autor:
Saori Sakaue, Etsuro Yamaguchi, Yoshikazu Inoue, Meiko Takahashi, Jun Hirata, Ken Suzuki, Satoru Ito, Toru Arai, Masaki Hirose, Yoshinori Tanino, Takefumi Nikaido, Toshio Ichiwata, Shinya Ohkouchi, Taizou Hirano, Toshinori Takada, Satoru Miyawaki, Shogo Dofuku, Yuichi Maeda, Takuro Nii, Toshihiro Kishikawa, Kotaro Ogawa, Tatsuo Masuda, Kenichi Yamamoto, Kyuto Sonehara, Ryushi Tazawa, Konosuke Morimoto, Masahiro Takaki, Satoshi Konno, Masaru Suzuki, Keisuke Tomii, Atsushi Nakagawa, Tomohiro Handa, Kiminobu Tanizawa, Haruyuki Ishii, Manabu Ishida, Toshiyuki Kato, Naoya Takeda, Koshi Yokomura, Takashi Matsui, Masaki Watanabe, Hiromasa Inoue, Kazuyoshi Imaizumi, Yasuhiro Goto, Hiroshi Kida, Tomoyuki Fujisawa, Takafumi Suda, Takashi Yamada, Yasuomi Satake, Hidenori Ibata, Nobuyuki Hizawa, Hideki Mochizuki, Atsushi Kumanogoh, Fumihiko Matsuda, Koh Nakata, Tomomitsu Hirota, Mayumi Tamari, Yukinori Okada
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Autoimmune pulmonary alveolar proteinosis (aPAP) is a complex lung disease caused by abnormal surfactant homeostasis. Here, the authors carry out a genome-wide association study of aPAP in a Japanese cohort, finding variants in the MHC and suggesting
Externí odkaz:
https://doaj.org/article/d9a62f084a8e4179916af621aeb86739
Autor:
Minako Shimaya, Yuji Inagaki, Toru Arai, Mayu Kawakami, Naoko Takeuchi, Hiromitsu Sumikawa, Shigeki Shimizu, Takayuki Takimoto, Yoshikazu Inoue
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 10, p1451-1457, 7p